Hairy Cell Leukemia Foundation 2023 CONFERENCE
Medical and Scientific Sessions
CONFERENCE DAY ONE - THURSDAY, OCTOBER 12, 2023
Location: Jefferies, 100 Bishopsgate, London
All listed times are in the United Kingdom/London time.
8:45 am to 9:30 am
Continental Breakfast and Networking
9:30 am to 9:45 am eastern
Opening Remarks from HCLF Leadership
9:45 am to 10:30 am
Research Presentation and Q&A (Zoom)
Dr. Thorsten Zenz, University Hospital Zürich
“Charting the Surfaceome to Eliminate Hairy Cell Leukemia”
Dr. Zenz is a current HCL2025 grantee.
10:30 am to 11:15 am
Research Presentation and Q&A (Zoom)
Dr. David Ritchie, Melbourne Health, Royal Melbourne Hospital-City Campus
“Integration of Molecular and Immunology Signals for Prognostication in HCL”
Dr. Ritchie is a current HCL2025 grantee.
11:15 am to 11:30 am
Break
11:30 am to 12:00 pm
Working Group: Updating the HCL Consensus Guidelines
Focus: Initial Treatment
Facilitator: Dr. Robert Kreitman, NIH
12:00 pm to 12:30 pm
Working Group: Updating the HCL Consensus Guidelines
Focus: Treatment at Relapse
Facilitator: Dr. Tamar Tadmor, Bnai-Zion Medical Center
12:35 pm to 1:10 pm
Lunch
1:15 pm to 2:00 pm
Research Presentation and Q&A
Dr. Clive Zent, University of Rochester James P. Wilmot Cancer Institute
“Splenic B Cell Lymphomas: Analysis of Immune Microenvironment”
Dr. Zent was a 2021/2022 HCL research grantee.
2:00 pm to 2:45 pm
Research Presentation and Q&A
Dr. Evgeny Arons and Dr. Chi-Ping Day, National Institutes of Health (NIH)
“Characterization of Hairy Cell Leukemia Variant and Unmutated IGHV4-34+ Expressing Variant by Whole Exome and Single Cell Sequencing”
Dr. Evgeny Arons is a current HCL research grantee with Dr. Robert Kreitman.
2:45 pm to 3:30 pm
Research Presentation and Q&A
Dr. Christopher Oakes and Kyoko Yamaguchi, The Ohio State University
“DNA Methylation-based Classification of Hairy Cell Leukemia and Splenic B Cell Lymphoma Reveals Novel Disease Mechanisms”
Dr. Oakes was a 2017 and 2020 HCL research grantee.
3:30 pm to 3:45 pm
Break
3:45 pm to 4:15 pm
Working Group: Updating the HCL Consensus Guidelines
Focus: HCL Variant
Facilitator: Dr. Clive Zent, University of Rochester James P. Wilmot Cancer Institute
4:15 pm to 4:45 pm
Working Group: Updating the HCL Consensus Guidelines (Zoom)
Focus: Infection prevention and treatment
Facilitator: Dr. Bernhard Wörmann, The Charité – Universitätsmedizin Berlin
4:45 pm to 5:00 pm
Wrap-up and Overview of Day Two
5:00 pm to 7:30 pm
Reception
Drinks and canapés hosted by the Hairy Cell Leukemia Foundation
Location: Paradise Green, 100 Bishopsgate, London
CONFERENCE DAY TWO - FRIDAY, OCTOBER 13, 2023
Location: Jefferies, 100 Bishopsgate, London
8:30 am to 9:00 am
Continental Breakfast
Location: Jefferies, London
9:00 am to 9:15 am
Welcome back from HCLF Leadership
9:15 am to 10:00 am
Research Presentation and Q&A
Dr. Jae Park, Sloan Kettering Institute for Cancer Research
“Chemotherapy-free Therapy for Classic HCL”
Dr. Jae Park and Dr. Omar Abdel-Wahab are current HCL2025 grantees.
10:00 am to 10:45 am
Research Presentation and Q&A
Dr. Enrico Tiacci, University of Perugia Institute of Hematology and Center for Hemato-Oncology Research
“Chemotherapy-free Strategies in Hairy Cell Leukemia”
Dr. Enrico Tiacci is a current HCL2025 grantee.
10:45 am to 11:00 am
Break
11:00 am to 11:30 am
Working Group: Updating the HCL Consensus Guidelines
Focus: Investigational Approaches
Facilitator: Dr. Enrico Tiacci, University of Perugia Institute of Hematology and Center for Hemato-Oncology Research
11:30 am to 12:15 pm
Research Presentation and Q&A
Dr. Marc Seifert, University Hospital Düsseldorf
“Exploiting Metabolic Dependencies, Tumor Plasticity and their Consequences for Drug Response of HCL”
Dr. Marc Seifert is a current HCL2025 grantee.
12:15 pm to 1:00 pm
Research Presentation and Q&A
Dr. Reshmi Parameswaran, Case Western Reserve University School of Medicine
“A Ligand-based CAR-T Therapy for HCL”
Dr. Reshmi Parameswaran is a current HCL2025 grantee.
1:00 pm to 1:30 pm
Lunch
1:30 pm to 2:15 pm
Research Presentation and Q&A (via Zoom)
Dr. Marco Ruella, Perelman School of Medicine at the University of Pennsylvania
“Precision Targeting of HCL using Chimeric Antigen Receptor T cells”
Dr. Marco Ruella is a current HCL2025 grantee.
2:15 pm to 2:45 pm
Research Presentation and Q&A (via Zoom)
Dr. Susan Slager, Mayo Clinic
“What a GWAS of HCL could provide: Modeled by CLL”
2:45 pm to 3:15 pm